New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

Frontiers Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID- 19

IJERPH, Free Full-Text

Coronavirus Drug and Treatment Tracker - The New York Times

Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

Frontiers Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial - The Lancet Respiratory Medicine

Annual Report to the Nation Part 2 pandemic cancer diagnoses - NCI

Post-acute COVID-19 syndrome and kidney diseases: what do we know?

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis

Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms - eClinicalMedicine

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research